JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis

Overview of attention for article published in BMC Infectious Diseases, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 4 news outlets

twitter: 7 X users

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 171 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 13,125 followers.

#sng #synairgen

19 Jan 2021

Reply Repost Favourite

RT @carterchar1: Another analysis showing the unique capacity of interferon beta to boost the immune response against the various strands o…

19 Jan 2021

Reply Repost Favourite

RT @carterchar1: Another analysis showing the unique capacity of interferon beta to boost the immune response against the various strands o…

19 Jan 2021

Reply Repost Favourite

Another analysis showing the unique capacity of interferon beta to boost the immune response against the various strands of Covid-19 #SNG #Synairgen https://t.co/9eMLk7AHxp

19 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.